Bank Of America Corp Editas Medicine, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 539,726 shares of EDIT stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

539,726

Previous 896,647 39.81%

Holding current value

$1.77 Million

Previous $6.65 Million 62.12%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.67 - $7.28 $1.67 Million - $2.6 Million	-356,921 Reduced 39.81%	539,726 $2.52 Million
Q1 2024 May 15, 2024	BUY	$7.03 - $11.07 $3.69 Million - $5.81 Million	524,563 Added 140.98%	896,647 $6.65 Million
Q4 2023 Feb 14, 2024	SELL	$6.25 - $11.11 $350,306 - $622,704	-56,049 Reduced 13.09%	372,084 $3.77 Million
Q2 2023 Aug 14, 2023	SELL	$6.36 - $11.47 $3.27 Million - $5.89 Million	-513,762 Reduced 54.55%	428,133 $3.52 Million
Q1 2023 May 12, 2023	BUY	$7.03 - $11.53 $567,531 - $930,816	80,730 Added 9.37%	941,895 $6.83 Million
Q4 2022 Feb 10, 2023	BUY	$8.32 - $13.21 $3.35 Million - $5.32 Million	402,363 Added 87.7%	861,165 $7.64 Million
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $1.99 Million - $3.18 Million	163,966 Added 55.61%	458,802 $5.62 Million
Q2 2022 Aug 12, 2022	SELL	$9.99 - $21.35 $101,828 - $217,620	-10,193 Reduced 3.34%	294,836 $3.49 Million
Q1 2022 May 16, 2022	BUY	$14.08 - $27.63 $451,742 - $886,480	32,084 Added 11.75%	305,029 $5.8 Million
Q4 2021 Feb 08, 2022	SELL	$26.55 - $40.57 $796,048 - $1.22 Million	-29,983 Reduced 9.9%	272,945 $7.25 Million
Q3 2021 Nov 15, 2021	BUY	$39.27 - $72.94 $2.39 Million - $4.43 Million	60,802 Added 25.11%	302,928 $12.4 Million
Q2 2021 Sep 13, 2021	BUY	$31.29 - $56.64 $7.58 Million - $13.7 Million	242,126 New	242,126 $13.7 Million

Others Institutions Holding EDIT

# of Institutions

242

Shares Held

58.9M

Call Options Held

494K

Put Options Held

417K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $225M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Editas Medicine, Inc. Transaction History